A
Alfons H. H. Bongaerts
Researcher at University Medical Center Groningen
Publications - 23
Citations - 1097
Alfons H. H. Bongaerts is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Pulmonary embolism & Angiography. The author has an hindex of 14, co-authored 23 publications receiving 1002 citations. Previous affiliations of Alfons H. H. Bongaerts include University of Groningen.
Papers
More filters
Journal ArticleDOI
Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: A prospective study
Matthijs Oudkerk,Edwin J. R. van Beek,Piotr A. Wielopolski,Peter M. A. van Ooijen,Elise M. J. Brouwers-Kuyper,Alfons H. H. Bongaerts,Arie Berghout +6 more
TL;DR: Results are similar to those obtained with helical computed tomography, but MRA has safer contrast agents and does not involve ionising radiation, and could become part of the diagnostic strategy for pulmonary embolism.
Journal ArticleDOI
Intravenous coronary angiography by electron beam computed tomography: a clinical evaluation
Benno J. Rensing,Alfons H. H. Bongaerts,R.J. Van Geuns,P. M. A. van Ooijen,Matthijs Oudkerk,P. J. De Feyter +5 more
TL;DR: Intravenous EBCT coronary angiography is a promising coronary imaging technique that can detect and rule out significant coronary artery disease of the left main proximal and mid portions of the LAD with good accuracy.
Journal ArticleDOI
89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
Sietske B. M. Gaykema,Carolien P. Schröder,Joanna Vitfell-Rasmussen,Sue Chua,Thijs H. Oude Munnink,Adrienne H. Brouwers,Alfons H. H. Bongaerts,Mikhail Akimov,Cristina Fernandez-Ibarra,Marjolijn N. Lub-de Hooge,Elisabeth G.E. de Vries,Charles Swanton,Udai Banerji +12 more
TL;DR: NVP-AUY922 showed proof-of-concept clinical response in HER2-amplified metastatic breast cancer, and early change on 89Zr-trastuzumab PET was positively associated with change in size of individual lesions assessed by CT.
Journal ArticleDOI
89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment
Sjoukje F. Oosting,Adrienne H. Brouwers,Suzanne C van Es,Wouter B. Nagengast,Thijs H. Oude Munnink,Marjolijn N. Lub-de Hooge,Harry Hollema,Johan R. de Jong,Igle J. de Jong,Sanne de Haas,Stefan Scherer,Wim J. Sluiter,Rudi Dierckx,Alfons H. H. Bongaerts,Jourik A. Gietema,Elisabeth G.E. de Vries +15 more
TL;DR: Tumor uptake of 89Zr-bevacizumab is high in mRCC, with remarkable interpatient and intrapatient heterogeneity, whereas sunitinib results in a modest reduction with an overshoot after 2 drug-free weeks.
Journal ArticleDOI
EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1
Sophie J. van Asselt,Adrienne H. Brouwers,Hendrik M. van Dullemen,Eric J. van der Jagt,Alfons H. H. Bongaerts,Ido P. Kema,K. P. Koopmans,Gerlof D. Valk,Henri J L M Timmers,Wouter W. de Herder,Richard A Feelders,Paul Fockens,Wim J. Sluiter,Elisabeth G.E. de Vries,Thera P. Links +14 more
TL;DR: EUS is superior to CT/MRI + SRS for pancreatic lesion detection in patients with MEN1 and is recommended as the first-choice pancreas imaging technique in patients in this setting, while C-5-HTP PET is not useful.